Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment

Paulo Rabna; Andreas Andersen; Christian Wejse; Ines Oliveira; Victor Francisco Gomes; Maya Bonde Haaland; Peter Aaby; Jesper Eugen-Olsen

doi:10.1371/journal.pone.0043933

Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment

Paulo Rabna
, Andreas Andersen
, Christian Wejse
, Ines Oliveira
, Victor Francisco Gomes
, Maya Bonde Haaland
, Peter Aaby
, Jesper Eugen-Olsen

Klinisk Forskningsafdeling

18 Citationer (Scopus)

Abstract

To investigate whether changes in the plasma level of soluble urokinase plasminogen activator receptor (suPAR) can be used to monitor tuberculosis (TB) treatment efficacy.

Originalsprog	Engelsk
Tidsskrift	P L o S One
Vol/bind	7
Udgave nummer	8
Sider (fra-til)	e43933
ISSN	1932-6203
DOI	https://doi.org/10.1371/journal.pone.0043933
Status	Udgivet - 2012

Adgang til dokumentet

10.1371/journal.pone.0043933

Citationsformater

@article{a4be7150fea94751994e49004076f7a6,

title = "Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment",

abstract = "To investigate whether changes in the plasma level of soluble urokinase plasminogen activator receptor (suPAR) can be used to monitor tuberculosis (TB) treatment efficacy.",

author = "Paulo Rabna and Andreas Andersen and Christian Wejse and Ines Oliveira and Gomes, \{Victor Francisco\} and Haaland, \{Maya Bonde\} and Peter Aaby and Jesper Eugen-Olsen",

year = "2012",

doi = "10.1371/journal.pone.0043933",

language = "English",

volume = "7",

pages = "e43933",

journal = "P L o S One",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "8",

}

TY - JOUR

T1 - Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment

AU - Rabna, Paulo

AU - Andersen, Andreas

AU - Wejse, Christian

AU - Oliveira, Ines

AU - Gomes, Victor Francisco

AU - Haaland, Maya Bonde

AU - Aaby, Peter

AU - Eugen-Olsen, Jesper

PY - 2012

Y1 - 2012

N2 - To investigate whether changes in the plasma level of soluble urokinase plasminogen activator receptor (suPAR) can be used to monitor tuberculosis (TB) treatment efficacy.

AB - To investigate whether changes in the plasma level of soluble urokinase plasminogen activator receptor (suPAR) can be used to monitor tuberculosis (TB) treatment efficacy.

U2 - 10.1371/journal.pone.0043933

DO - 10.1371/journal.pone.0043933

M3 - Journal article

C2 - 22937128

SN - 1932-6203

VL - 7

SP - e43933

JO - P L o S One

JF - P L o S One

IS - 8

ER -

Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater